The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real‐world study from Turkey-Reference-Cited by-同舟云学术

The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real‐world study from Turkey

Published:2021-04-08 Issue:7 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Uzunköprü Cihat¹^ORCID,Tütüncü Melih²^ORCID,Gündüz Tuncay³^ORCID,Gümüş Haluk⁴^ORCID,Şen Sedat⁵^ORCID,Demir Serkan⁶^ORCID,Çınar Bilge Piri⁷^ORCID,Türe Hatice Sabiha¹^ORCID,Uygunoğlu Uğur²^ORCID,Toğrol Rıfat Erdem⁸^ORCID,Terzi Murat⁵^ORCID,Kürtüncü Murat³^ORCID,Özakbaş Serkan⁹^ORCID,Tütüncü Mesude¹⁰^ORCID,Beckmann Yeşim¹^ORCID,Siva Aksel²^ORCID

Affiliation:

1. Department of Neurology Faculty of Medicine İzmir Katip Çelebi University Izmir Turkey

2. Department of Neurology Cerrahpaşa School of MedicineIstanbul University Istanbul Turkey

3. Department of Neurology Istanbul Faculty of Medicine Istanbul University Istanbul Turkey

4. Department of Neurology Faculty of Medicine Konya Selçuk University Konya Turkey

5. Department of Neurology Faculty of Medicine Samsun 19 Mayıs University Samsun Turkey

6. Department of Neurology Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital Istanbul Turkey

7. Department of Neurology Faculty of Medicine Bülent Ecevit University Zonguldak Turkey

8. Department of Neurology Sultan Abdülhamid Han Training and Research Hospital Istanbul Turkey

9. Department of Neurology Faculty of Medicine 9 Eylül University Izmir Turkey

10. Department of Neurology Prof Dr Mazhar Osman Mental Health and Neurology Training and Research Hospital Istanbul Turkey

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14158

Reference42 articles.

1. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

2. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum

3. Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide

4. Aquaporin-4 autoimmunity

5. Epidemiology of Neuromyelitis Optica in the United States

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion;Neurology Neuroimmunology & Neuroinflammation;2024-07

2. Rituximab Therapy for Immune-Mediated Neurological Diseases: Our Experience at a Tertiary Care Centre;Cureus;2024-06-12

3. Systematic Review of Treatment Options and Therapeutic Responses for Lesions of the Sella and Orbit: Evidence-Based Recommendations;World Neurosurgery;2023-05

4. Different doses of Rituximab for the therapy of Neuromyelitis optica spectrum disorder: A systematic review and meta-analysis;Multiple Sclerosis and Related Disorders;2022-12

5. A meta-analysis on efficacy and safety of rituximab for neuromyelitis optica spectrum disorders;Medicine;2022-09-09